{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:01:19Z","timestamp":1774306879176,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Novartis Pharma AG"},{"name":"Novartis Finland Oy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A global <jats:italic>My Migraine Voice<\/jats:italic> survey was conducted in 31 countries among 11,266 adults who suffered from \u22654 monthly migraine days (MMD). The aim of this retrospective observational survey-based study was to analyse the country specific results in Finland in order to understand the impact of migraine based on disease severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The included participants (3%, <jats:italic>n<\/jats:italic>\u2009=\u2009338\/11,266) were stratified by mean MMDs into 4\u2009\u2264\u2009MMD\u2009&lt;\u20098 (<jats:italic>n<\/jats:italic>\u2009=\u2009133), 8\u2009\u2264\u2009MMD\u2009&lt;\u200915 (<jats:italic>n<\/jats:italic>\u2009=\u2009139) and MMD\u2009\u2265\u200915 (<jats:italic>n<\/jats:italic>\u2009=\u200966) subgroups. Comorbidities, migraine-related emotional burden and impact on daily living and work productivity and activity impairment (WPAI) were assessed. Subgroup analysis on healthcare resource utilization (HCRU) due to migraine was assessed by visits to healthcare practitioners (HCPs) during the past 6\u2009months and by hospitalizations and emergency room (ER) visits during the past 12\u2009months. The group difference was tested using the one-way ANOVA and for categorical variables using the Chi-squared test. The association between HCRU and MMD and number of comorbidities was assessed using negative binomial regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Mean age was 44\u2009years, 93% were women and 67% (<jats:italic>n<\/jats:italic>\u2009=\u2009227) were employed. Chronic migraine (CM, MMD\u2009\u2265\u200915) was reported in 19.5% of the respondents. The negative impact on daily functioning and emotional burden increased significantly by migraine frequency. Mean number of comorbidities was 2.4, and mean number of HCP visits during the previous 6 months was 5.9. Increase in migraine frequency and comorbidities was associated with higher HCRU. Eighty-eight percent of the respondents reported negative impact on working life and 52% experienced overall work productivity impairment. Over previous month, the mean number of missed working days for all respondents was 2.8\u2009days of which 54% were paid sick leave days, and in CM up to 6.0\u2009days and 30%, respectively. Both absenteeism and presenteeism were higher in the CM group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The emotional and functional burden was high, and the societal burden increased by frequency and severity of migraine, as shown by higher HCRU and reduced work productivity. There is a need to improve quality of care in migraine and improve migraine management related issues in both healthcare and society in Finland.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-020-01185-4","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T12:03:11Z","timestamp":1601380991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland"],"prefix":"10.1186","volume":"21","author":[{"given":"Marja-Liisa","family":"Sumelahti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Sumanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merika S.","family":"Sumanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuli","family":"Tuominen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Vikkula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanna M.","family":"Honkala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stina","family":"Rosqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minna A.","family":"Korolainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"1185_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"LJ Stovner","year":"2018","unstructured":"Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM et al (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 17:954\u2013976","journal-title":"Lancet Neurol"},{"key":"1185_CR2","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/head.12407","volume":"54","author":"SD Silberstein","year":"2014","unstructured":"Silberstein SD, Lipton RB, Dodick DW (2014) Operational diagnostic criteria for chronic migraine: expert opinion. Headache 54:1258\u20131266","journal-title":"Headache"},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z (2018) Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain 19:17 10.1186\/s10194\u2013018\u20130846\u20132","journal-title":"J Headache Pain"},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10194-019-0993-0","volume":"20","author":"M Leonardi","year":"2019","unstructured":"Leonardi M, Raggi A (2019) A narrative review on the burden of migraine: when the burden is the impact on people\u2019s life. J Headache Pain 20:41","journal-title":"J Headache Pain"},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629\u2013808","journal-title":"Cephalalgia"},{"key":"1185_CR6","first-page":"1","volume":"0","author":"MA Chalmer","year":"2019","unstructured":"Chalmer MA, Hansen TF, Lebedeva ER, Dodick DW, Lipton RB, Olesen J (2019) Proposed new diagnostic criteria for chronic migraine. Cephalalgia. 0:1\u20138","journal-title":"Cephalalgia."},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1111\/head.13421","volume":"58","author":"SD Silberstein","year":"2018","unstructured":"Silberstein SD, Lee L, Gandhi K, Fitzgerald T, Bell J, Cohen JM (2018) Health care resource utilization and migraine disability along the migraine continuum among patients treated for migraine: headache. Headache 58:1579\u20131592","journal-title":"Headache"},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11916-011-0233-z","volume":"16","author":"Z Katsarava","year":"2012","unstructured":"Katsarava Z, Buse DC, Manack AN, Lipton RB (2012) Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep 16:86\u201392","journal-title":"Curr Pain Headache Rep"},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11916-010-0157-z","volume":"15","author":"AN Manack","year":"2011","unstructured":"Manack AN, Buse DC, Lipton RB (2011) Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep 15:70\u201378","journal-title":"Curr Pain Headache Rep"},{"key":"1185_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10194-008-0038-6","volume":"9","author":"LJ Stovner","year":"2008","unstructured":"On behalf of the Eurolight Steering Committee, Stovner LJ, Andr\u00e9e C (2008) Impact of headache in Europe: a review for the Eurolight project. J Headache Pain 9:139\u2013146","journal-title":"J Headache Pain"},{"key":"1185_CR11","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1526-4610.2011.01945.x","volume":"51","author":"M Stokes","year":"2011","unstructured":"Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L et al (2011) Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the international burden of migraine study (IBMS): July\/august 2011. Headache 51:1058\u20131077","journal-title":"Headache"},{"key":"1185_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0333102410381145","volume":"31","author":"A Blumenfeld","year":"2011","unstructured":"Blumenfeld A, Varon S, Wilcox T, Buse D, Kawata A, Manack A et al (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the international burden of migraine study (IBMS). Cephalalgia. 31:301\u2013315","journal-title":"Cephalalgia."},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1526-4610.2011.02046.x","volume":"52","author":"D Buse","year":"2012","unstructured":"Buse D, Manack A, Serrano D, Reed M, Varon S, Turkel C et al (2012) Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study. Headache 52:3\u201317","journal-title":"Headache"},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/ene.12380","volume":"21","author":"I Ayzenberg","year":"2014","unstructured":"Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G et al (2014) Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol 21:758\u2013765","journal-title":"Eur J Neurol"},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/0333102414552532","volume":"35","author":"AM Adams","year":"2015","unstructured":"Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM et al (2015) The impact of chronic migraine: the chronic migraine epidemiology and outcomes (CaMEO) study methods and baseline results. Cephalalgia. 35:563\u2013578","journal-title":"Cephalalgia."},{"key":"1185_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-018-0946-z","volume":"19","author":"P Martelletti","year":"2018","unstructured":"Martelletti P, Schwedt TJ, Lanteri-Minet M, Quintana R, Carboni V, Diener H-C et al (2018) My migraine voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. J Headache Pain 19:115","journal-title":"J Headache Pain"},{"key":"1185_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s10194-019-0964-5","volume":"20","author":"MA Korolainen","year":"2019","unstructured":"Korolainen MA, Kurki S, Lassenius MI, Toppila I, Costa-Scharplatz M, Purmonen T et al (2019) Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care. J Headache Pain 20:13","journal-title":"J Headache Pain"},{"key":"1185_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s10194-006-0319-x","volume":"7","author":"V Artto","year":"2006","unstructured":"Artto V, Wessman M, Nissil\u00e4 M, S\u00e4k\u00f6 E, Liukkonen J, Teirmaa H et al (2006) Comorbidity in Finnish migraine families. J Headache Pain 7:324\u2013330","journal-title":"J Headache Pain"},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s10194-020-1077-x","volume":"21","author":"MA Korolainen","year":"2020","unstructured":"Korolainen MA, Tuominen S, Kurki S, Lassenius MI, Toppila I, Purmonen T et al (2020) Burden of migraine in Finland: multimorbidity and phenotypic disease networks in occupational healthcare. J Headache Pain 21:8","journal-title":"J Headache Pain"},{"key":"1185_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s10194-019-1015-y","volume":"20","author":"F Hjalte","year":"2019","unstructured":"Hjalte F, Olofsson S, Persson U, Linde M (2019) Burden and costs of migraine in a Swedish defined patient population \u2013 a questionnaire-based study. J Headache Pain 20:65","journal-title":"J Headache Pain"},{"key":"1185_CR21","unstructured":"Ruiz de la Torre E, Martelletti P, Craven A. Real-world patient perspective on the burden and impact of migraine. Real-world patient perspective on the burden and impact of migraine. Vancouver September 7\u201310; 2017. p. Poster #PO-02-184"},{"key":"1185_CR22","unstructured":"Ruiz de la Torre E, Martelletti P, Craven A. Burden and impact of migraine: a caregiver\u2019s perspective. Burden and impact of migraine: a caregiver\u2019s perspective. Vancouver September 7\u201310; 2017. p. Poster #PO-02-185"},{"key":"1185_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM (1993) The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument. Pharmacoeconomics 4:353\u2013365","journal-title":"Pharmacoeconomics"},{"key":"1185_CR24","unstructured":"Reilly M. WPAI Scoring [Internet]. WPAI Scoring. Available from: http:\/\/www.reillyassociates.net\/WPAI_Scoring.html. [cited 2020 Feb 26]."},{"key":"1185_CR25","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2017","unstructured":"R Core Team (2017) R: A language and environment for statistical computing. R Foundation for statistical Computing, Vienna Available from: https:\/\/www.R-project.org\/"},{"key":"1185_CR26","volume-title":"SPC Botox","author":"Fimea","year":"2019","unstructured":"Fimea. SPC Botox. 2019. Available from: https:\/\/spc.fimea.fi\/indox\/nam\/html\/nam\/humspc\/5\/10953175.pdf. [cited 2020 May 20]"},{"key":"1185_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s10194-018-0907-6","volume":"19","author":"P Vo","year":"2018","unstructured":"Vo P, Fang J, Bilitou A, Laflamme AK, Gupta S (2018) Patients\u2019 perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. J Headache Pain 19:82","journal-title":"J Headache Pain"},{"key":"1185_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1468-2982.2009.01941.x","volume":"30","author":"J Natoli","year":"2010","unstructured":"Natoli J, Manack A, Dean B, Butler Q, Turkel C, Stovner L et al (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia. 30:599\u2013609","journal-title":"Cephalalgia."},{"key":"1185_CR29","unstructured":"Women\u2019s employment in the EU. Available from: https:\/\/ec.europa.eu\/eurostat\/web\/products-eurostat-news\/-\/EDN-20200306-1. [cited 2020 Apr 20]"},{"key":"1185_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1468-1331.2011.03590.x","volume":"19","author":"J Olesen","year":"2012","unstructured":"Olesen J, Gustavsson A, Svensson M, Wittchen H-U, J\u00f6nsson B (2012) On behalf of the CDBE2010 study group, et al. the economic cost of brain disorders in Europe: economic cost of brain disorders in Europe. Eur J Neurol 19:155\u2013162","journal-title":"Eur J Neurol"},{"key":"1185_CR31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","volume":"19","author":"M Linde","year":"2012","unstructured":"Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barr\u00e9 J, Katsarava Z et al (2012) The cost of headache disorders in Europe: the Eurolight project: cost of headache in Europe. Eur J Neurol 19:703\u2013711","journal-title":"Eur J Neurol"},{"key":"1185_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1526-4610.2008.01263.x","volume":"49","author":"A Radtke","year":"2009","unstructured":"Radtke A, Neuhauser H (2009) Prevalence and burden of headache and migraine in Germany. Headache 49:79\u201389","journal-title":"Headache"},{"key":"1185_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s10194-015-0584-7","volume":"16","author":"M Allena","year":"2015","unstructured":"Allena M, Steiner TJ, Sances G, Carugno B, Balsamo F, Nappi G et al (2015) Impact of headache disorders in Italy and the public-health and policy implications: a population-based study within the Eurolight project. J Headache Pain 16:100","journal-title":"J Headache Pain"},{"key":"1185_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1526-4610.2002.04262.x","volume":"42","author":"J Edmeads","year":"2002","unstructured":"Edmeads J, Mackell JA (2002) The economic impact of migraine: an analysis of direct and indirect costs. Headache 42:501\u2013509","journal-title":"Headache"},{"key":"1185_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10194-012-0460-7","volume":"13","author":"LM Bloudek","year":"2012","unstructured":"Bloudek LM, Stokes M, Buse DC, Wilcox TK, Lipton RB, Goadsby PJ et al (2012) Cost of healthcare for patients with migraine in five European countries: results from the international burden of migraine study (IBMS). J Headache Pain 13:361\u2013378","journal-title":"J Headache Pain"},{"key":"1185_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1526-4610.2007.00993.x","volume":"48","author":"N Jette","year":"2008","unstructured":"Jette N, Patten S, Williams J, Becker W, Wiebe S (2008) Comorbidity of migraine and psychiatric disorders\u2014a National Population-Based Study. Headache 48:501\u2013516","journal-title":"Headache"},{"key":"1185_CR37","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1177\/070674370505001305","volume":"50","author":"CV Molgat","year":"2005","unstructured":"Molgat CV, Patten SB (2005) Comorbidity of major depression and migraine \u2014 a Canadian population-based study. Can J Psychiatr 50:832\u2013837","journal-title":"Can J Psychiatr"},{"key":"1185_CR38","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1526-4610.2007.00810.x","volume":"47","author":"GE Tietjen","year":"2007","unstructured":"Tietjen GE, Peterlin BL, Brandes JL, Hafeez F, Hutchinson S, Martin VT et al (2007) Depression and anxiety: effect on the migraine\u2013obesity relationship. Headache 47:866\u2013875","journal-title":"Headache"},{"key":"1185_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ane.12919","volume":"138","author":"M-L Sumelahti","year":"2018","unstructured":"Sumelahti M-L, Mattila K, Sumanen M (2018) Painful musculosceletal disorders and depression among working aged migraineurs. Acta Neurol Scand 138:93\u201398","journal-title":"Acta Neurol Scand"},{"key":"1185_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00702-019-02107-8","volume":"127","author":"G Affaitati","year":"2020","unstructured":"Affaitati G, Costantini R, Tana C, Cipollone F, Giamberardino MA (2020) Co-occurrence of pain syndromes. J Neural Transm 127:625\u2013646","journal-title":"J Neural Transm"},{"key":"1185_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s10194-016-0619-8","volume":"17","author":"MA Giamberardino","year":"2016","unstructured":"Giamberardino MA, Affaitati G, Martelletti P, Tana C, Negro A, Lapenna D et al (2016) Impact of migraine on fibromyalgia symptoms. J Headache Pain 17:28","journal-title":"J Headache Pain"},{"key":"1185_CR42","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1526-4610.2009.01369.x","volume":"49","author":"J Munakata","year":"2009","unstructured":"Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MFT, Tierce J et al (2009) Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache 49:498\u2013508","journal-title":"Headache"},{"key":"1185_CR43","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1177\/0333102415620251","volume":"36","author":"K Laurell","year":"2016","unstructured":"Laurell K, Artto V, Bendtsen L, Hagen K, H\u00e4ggstr\u00f6m J, Linde M et al (2016) Premonitory symptoms in migraine: a cross-sectional study in 2714 persons. Cephalalgia. 36:951\u2013959","journal-title":"Cephalalgia."},{"key":"1185_CR44","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1177\/0333102411427602","volume":"31","author":"M-L Sumelahti","year":"2011","unstructured":"Sumelahti M-L, Mattila K, Sillanm\u00e4ki L, Sumanen M (2011) Prescription patterns in preventive and abortive migraine medication. Cephalalgia. 31:1659\u20131663","journal-title":"Cephalalgia."},{"key":"1185_CR45","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/head.12553","volume":"55","author":"D Serrano","year":"2015","unstructured":"Serrano D, Buse DC, Manack Adams A, Reed ML, Lipton RB (2015) Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache 55:502\u2013518","journal-title":"Headache"},{"key":"1185_CR46","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00228-016-2028-y","volume":"72","author":"P Frisk","year":"2016","unstructured":"Frisk P, Sporrong SK, Ljunggren G, Wettermark B, von Euler M (2016) Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden. Eur J Clin Pharmacol 72:747\u2013754","journal-title":"Eur J Clin Pharmacol"},{"key":"1185_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s10194-019-1000-5","volume":"20","author":"C Tiseo","year":"2019","unstructured":"Tiseo C, Ornello R, Pistoia F, Sacco S (2019) How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice. J Headache Pain 20:49","journal-title":"J Headache Pain"},{"key":"1185_CR48","doi-asserted-by":"publisher","first-page":"e71264","DOI":"10.1371\/journal.pone.0071264","volume":"8","author":"A Goren","year":"2013","unstructured":"Goren A, Liu X, Gupta S, Simon TA, Phatak H (2013) Quality of Life, Activity Impairment, and Healthcare Resource Utilization Associated with Atrial Fibrillation in the US National Health and Wellness Survey. PLoS One 8:e71264 Baradaran HR, editor","journal-title":"PLoS One"},{"key":"1185_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1477-7525-10-81","volume":"10","author":"I Kalsekar","year":"2012","unstructured":"Kalsekar I, Wagner J-S, DiBonaventura M, Bates J, Forbes R, Hebden T (2012) Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and wellness survey. Health Qual Life Outcomes 10:81","journal-title":"Health Qual Life Outcomes"},{"key":"1185_CR50","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/01.WNL.0000078940.53438.83","volume":"61","author":"RB Lipton","year":"2003","unstructured":"Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J et al (2003) A self-administered screener for migraine in primary care: the ID migraine\u2122 validation study. Neurology 61:375\u2013382","journal-title":"Neurology"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-020-01185-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-020-01185-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-020-01185-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T23:06:23Z","timestamp":1632870383000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-020-01185-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1186\/s10194-020-01185-4","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Participants were recruited by means of existing online panels (GfK Health) and support organizations for people with migraine. Participants\u2019 consent was obtained prior to participation in the survey. Survey data were handled confidentially, and anonymity of respondents was maintained throughout the study. As such, and due to its research format, this study was exempted from ethics committee review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SR is employed by Novartis; MK was employed by Novartis and is currently employed by Orion Coorporation; ST, JV and SMH are employed by Medaffcon. MLS, MS and MSS do not have competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}